|
gptkbp:instance_of
|
gptkb:Company
|
|
gptkbp:acquisition
|
gptkb:Nant_Health
Adna Gen AG
|
|
gptkbp:awards
|
gptkb:Frost_&_Sullivan_Award
gptkb:Deloitte_Technology_Fast_500
Red Herring Top 100
Austin Business Journal Best Places to Work
|
|
gptkbp:ceo
|
Nachum Shamir
|
|
gptkbp:collaboration
|
gptkb:Centers_for_Disease_Control_and_Prevention
gptkb:World_Health_Organization
gptkb:National_Institutes_of_Health
gptkb:U._S._Department_of_Defense
gptkb:U._S._Food_and_Drug_Administration
|
|
gptkbp:competitors
|
gptkb:Bio-Rad_Laboratories
gptkb:Abbott_Laboratories
gptkb:Roche_Diagnostics
gptkb:Thermo_Fisher_Scientific
gptkb:Qiagen
|
|
gptkbp:employees
|
approximately 500
|
|
gptkbp:founded
|
gptkb:1995
|
|
gptkbp:founder
|
H. David Mc Culloch
|
|
gptkbp:headquarters
|
gptkb:Austin,_Texas
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Luminex Corporation
|
|
gptkbp:industry
|
gptkb:biotechnology
|
|
gptkbp:location
|
gptkb:Europe
gptkb:Asia
gptkb:North_America
|
|
gptkbp:market
|
Biopharmaceutical market
Diagnostics market
Clinical laboratory market
Point-of-care testing market
Research market
|
|
gptkbp:partnership
|
gptkb:Merck_KGa_A
gptkb:Abbott_Laboratories
gptkb:Thermo_Fisher_Scientific
|
|
gptkbp:products
|
MAGPIX
Luminex 200
x MAP Technology
|
|
gptkbp:research_focus
|
Infectious diseases
Genetic testing
Pharmacogenomics
Biomarker discovery
Cancer diagnostics
|
|
gptkbp:revenue
|
$200 million (2020)
|
|
gptkbp:services
|
Molecular diagnostics
Clinical laboratory services
|
|
gptkbp:stock_symbol
|
LMNX
|
|
gptkbp:subsidiary
|
Luminex Corporation Canada
Luminex Corporation Europe
Luminex Molecular Diagnostics
|
|
gptkbp:technology
|
PCR
Multiplexing
Flow cytometry
|
|
gptkbp:website
|
www.luminexcorp.com
|
|
gptkbp:bfsParent
|
gptkb:Perkin-Elmer_Corporation
|
|
gptkbp:bfsLayer
|
5
|